In the last 12 months, insiders at Bausch & Lomb Corp ($BLCO) filed 153 transactions with the SEC: 12 open-market purchases totaling $1,997,160 and 0 sales totaling $0. Net insider sentiment: net buying.
Bausch & Lomb Corp operates in the Ophthalmic goods industry (Industrial Applications and Services sector).
Most Active Insiders
- SAUNDERS BRENT L (CEO and Chairman of the Board) — 16 transactions totaling $4,857,503
- Eldessouky Sam (EVP and CFO) — 17 transactions totaling $1,923,615
- Bailey A Robert D (EVP & Chief Legal Officer) — 12 transactions totaling $719,089
- Hashad Yehia (EVP of R&D and CMO) — 15 transactions totaling $556,228
- Bonnefoy Luc (President, Surgical) — 8 transactions totaling $372,032
View all SEC Filings for Bausch & Lomb Corp (BLCO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Bailey A Robert D | EVP & Chief Legal Officer | P | Common Shares, No Par Value | 14600 | $17.15 | 231,890.0000 | 354,318,198 | 6.72% | 0.00% |
| March 6, 2026 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 14700 | $0.00 | 981,275.0000 | 354,318,198 | 1.52% | 0.00% |
| March 6, 2026 | Bailey A Robert D | EVP & Chief Legal Officer | A | Common Shares, No Par Value | 14600 | $0.00 | 246,490.0000 | 354,318,198 | 6.30% | 0.00% |
| March 6, 2026 | Eldessouky Sam | EVP and CFO | P | Common Shares, No Par Value | 4000 | $17.13 | 403,130.0000 | 354,318,198 | 1.00% | 0.00% |
| March 6, 2026 | Eldessouky Sam | EVP and CFO | A | Common Shares, No Par Value | 4000 | $0.00 | 407,130.0000 | 354,318,198 | 0.99% | 0.00% |
| March 6, 2026 | SAUNDERS BRENT L | CEO and Chairman of the Board | P | Common Shares, No Par Value | 14700 | $17.14 | 966,575.0000 | 354,318,198 | 1.54% | 0.00% |
| March 3, 2026 | Ross Thomas W. Sr. | Director | P | Common Shares, No Par Value | 4500 | $17.68 | 64,891.0000 | 354,318,198 | 7.45% | 0.00% |
| March 3, 2026 | Ross Thomas W. Sr. | Director | A | Common Shares, No Par Value | 4500 | $0.00 | 69,391.0000 | 354,318,198 | 6.93% | 0.00% |
| March 2, 2026 | Alfonso Eduardo | Director | A | Common Shares, No Par Value | 4300 | $0.00 | 13,855.0000 | 354,318,198 | 45.00% | 0.00% |
| March 2, 2026 | Alfonso Eduardo | Director | P | Common Shares, No Par Value | 4300 | $17.90 | 9,555.0000 | 354,318,198 | 81.83% | 0.00% |
| Feb. 27, 2026 | VON ESCHENBACH ANDREW C. | Director | A | Common Shares, No Par Value | 4364 | $0.00 | 70,814.0000 | 354,318,198 | 6.57% | 0.00% |
| Feb. 27, 2026 | VON ESCHENBACH ANDREW C. | Director | P | Common Shares, No Par Value | 4364 | $18.31 | 66,450.0000 | 354,318,198 | 7.03% | 0.00% |
| Feb. 27, 2026 | Stewart Andrew J. | President, GPIC | F | Common Shares, No Par Value | 2007 | $18.30 | 90,649.0000 | 354,318,198 | 2.17% | 0.00% |
| Feb. 26, 2026 | Bonnefoy Luc | President, Surgical | F | Common Shares, No Par Value | 4404 | $18.49 | 113,533.0000 | 354,318,198 | 3.73% | 0.00% |
| Feb. 27, 2026 | Bonnefoy Luc | President, Surgical | F | Common Shares, No Par Value | 4311 | $18.30 | 109,222.0000 | 354,318,198 | 3.80% | 0.00% |
| Feb. 27, 2026 | Bonnefoy Luc | President, Surgical | F | Common Shares, No Par Value | 9221 | $18.30 | 100,001.0000 | 354,318,198 | 8.44% | 0.00% |
| Feb. 26, 2026 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2169 | $18.49 | 196,737.0000 | 354,318,198 | 1.09% | 0.00% |
| Feb. 27, 2026 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 5075 | $18.30 | 191,662.0000 | 354,318,198 | 2.58% | 0.00% |
| Feb. 27, 2026 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 11621 | $18.30 | 180,041.0000 | 354,318,198 | 6.06% | 0.00% |
| Feb. 26, 2026 | Bailey A Robert D | EVP & Chief Legal Officer | F | Common Shares, No Par Value | 3395 | $18.49 | 219,751.0000 | 354,318,198 | 1.52% | 0.00% |
| Feb. 26, 2026 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 2042 | $18.49 | 106,442.0000 | 354,318,198 | 1.88% | 0.00% |
| Feb. 27, 2026 | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 24649 | $18.30 | 951,875.0000 | 354,318,198 | 2.52% | 0.01% |
| Feb. 26, 2026 | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 22059 | $18.49 | 976,524.0000 | 354,318,198 | 2.21% | 0.01% |
| Feb. 27, 2026 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 51470 | $18.30 | 399,130.0000 | 354,318,198 | 11.42% | 0.01% |
| Feb. 27, 2026 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 15507 | $18.30 | 450,600.0000 | 354,318,198 | 3.33% | 0.00% |
| Feb. 26, 2026 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 7062 | $18.49 | 466,107.0000 | 354,318,198 | 1.49% | 0.00% |
| Feb. 27, 2026 | Bailey A Robert D | EVP & Chief Legal Officer | F | Common Shares, No Par Value | 2461 | $18.30 | 217,290.0000 | 354,318,198 | 1.12% | 0.00% |
| Feb. 27, 2026 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 2437 | $18.30 | 104,005.0000 | 354,318,198 | 2.29% | 0.00% |
| Feb. 27, 2026 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 5692 | $18.30 | 98,313.0000 | 354,318,198 | 5.47% | 0.00% |
| Feb. 26, 2026 | Stewart Andrew J. | President, GPIC | F | Common Shares, No Par Value | 2984 | $18.49 | 92,656.0000 | 354,318,198 | 3.12% | 0.00% |
| Feb. 25, 2026 | Munsch Frederick | SVP, Controller and CAO | A | Common Shares, No Par Value | 18253 | $0.00 | 108,484.0000 | 354,318,198 | 20.23% | 0.01% |
| Feb. 25, 2026 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 327102 | $0.00 | 998,583.0000 | 354,318,198 | 48.71% | 0.09% |
| Feb. 25, 2026 | Eldessouky Sam | EVP and CFO | A | Common Shares, No Par Value | 81775 | $0.00 | 473,169.0000 | 354,318,198 | 20.89% | 0.02% |
| Feb. 25, 2026 | Bailey A Robert D | EVP & Chief Legal Officer | A | Common Shares, No Par Value | 52570 | $0.00 | 223,146.0000 | 354,318,198 | 30.82% | 0.01% |
| Feb. 25, 2026 | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 35046 | $0.00 | 198,906.0000 | 354,318,198 | 21.39% | 0.01% |
| Feb. 25, 2026 | Stewart Andrew J. | President, GPIC | A | Common Shares, No Par Value | 32710 | $0.00 | 95,640.0000 | 354,318,198 | 51.98% | 0.01% |
| Feb. 25, 2026 | Bonnefoy Luc | President, Surgical | A | Common Shares, No Par Value | 30373 | $0.00 | 117,937.0000 | 354,318,198 | 34.69% | 0.01% |
| Feb. 23, 2026 | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 65444 | $17.99 | 671,481.0000 | 354,318,198 | 8.88% | 0.02% |
| Feb. 23, 2026 | COLLIS STEVEN H | Director | P | Common Shares, No Par Value | 15000 | $17.81 | 20,255.0000 | 354,318,198 | 285.44% | 0.00% |
| Feb. 23, 2026 | COLLIS STEVEN H | Director | A | Common Shares, No Par Value | 4491 | $0.00 | 24,746.0000 | 354,318,198 | 22.17% | 0.00% |
| Feb. 20, 2026 | ROBERTSON RUSSEL C | Director | P | Common Shares, No Par Value | 4400 | $17.90 | 72,407.0000 | 354,318,198 | 6.47% | 0.00% |
| Feb. 20, 2026 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 4400 | $0.00 | 76,807.0000 | 354,318,198 | 6.08% | 0.00% |
| Feb. 19, 2026 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 1451 | $17.65 | 68,007.0000 | 354,318,198 | 2.18% | 0.00% |
| Feb. 19, 2026 | Alfonso Eduardo | Director | A | Common Shares, No Par Value | 5255 | $0.00 | 5,255.0000 | 354,318,198 | 9999.99% | 0.00% |
| Feb. 19, 2026 | COLLIS STEVEN H | Director | A | Common Shares, No Par Value | 5255 | $0.00 | 5,255.0000 | 354,318,198 | 9999.99% | 0.00% |
| Feb. 19, 2026 | Ling Karen | Director | P | Common Shares, No Par Value | 4000 | $17.74 | 41,676.0000 | 354,318,198 | 10.62% | 0.00% |
| Feb. 19, 2026 | Ling Karen | Director | A | Common Shares, No Par Value | 4000 | $0.00 | 45,676.0000 | 354,318,198 | 9.60% | 0.00% |
| Feb. 19, 2026 | Paulson John | Director | A | Common Shares, No Par Value | 1239 | $17.65 | 72,606.0000 | 354,318,198 | 1.74% | 0.00% |
| Feb. 18, 2026 | Munsch Frederick | SVP, Controller and CAO | A | Common Shares, No Par Value | 12498 | $0.00 | 90,231.0000 | 354,318,198 | 16.08% | 0.00% |
| Feb. 18, 2026 | Bonnefoy Luc | President, Surgical | A | Common Shares, No Par Value | 10202 | $0.00 | 87,564.0000 | 354,318,198 | 13.19% | 0.00% |
| Feb. 18, 2026 | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 29406 | $0.00 | 163,860.0000 | 354,318,198 | 21.87% | 0.01% |
| Feb. 18, 2026 | Eldessouky Sam | EVP and CFO | A | Common Shares, No Par Value | 70578 | $0.00 | 391,394.0000 | 354,318,198 | 22.00% | 0.02% |
| Nov. 14, 2025 | Paulson John | Director | A | Common Shares, No Par Value | 1402 | $15.60 | 71,367.0000 | 354,189,784 | 2.00% | 0.00% |
| Nov. 14, 2025 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 1642 | $15.60 | 66,556.0000 | 354,189,784 | 2.53% | 0.00% |
| Aug. 5, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 4231 | $14.44 | 736,925.0000 | 352,470,796 | 0.57% | 0.00% |
| Aug. 5, 2025 | Bonnefoy Luc | President, Surgical | A | Common Shares, No Par Value | 6146 | $0.00 | 77,362.0000 | 352,470,796 | 8.63% | 0.00% |
| Aug. 5, 2025 | Eldessouky Sam | EVP and CFO | A | Common Shares, No Par Value | 42517 | $0.00 | 320,816.0000 | 352,470,796 | 15.28% | 0.01% |
| Aug. 5, 2025 | Munsch Frederick | SVP, Controller and CAO | A | Common Shares, No Par Value | 7529 | $0.00 | 77,733.0000 | 352,470,796 | 10.72% | 0.00% |
| Aug. 5, 2025 | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 17715 | $0.00 | 134,454.0000 | 352,470,796 | 15.17% | 0.01% |
| July 25, 2025 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2841 | $14.32 | 116,739.0000 | 352,470,796 | 2.38% | 0.00% |
| July 25, 2025 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 3996 | $14.32 | 278,299.0000 | 352,470,796 | 1.42% | 0.00% |
| July 25, 2025 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 1090 | $14.32 | 70,204.0000 | 352,470,796 | 1.53% | 0.00% |
| July 25, 2025 | Bonnefoy Luc | President, Surgical | F | Common Shares, No Par Value | 2167 | $14.32 | 71,216.0000 | 352,470,796 | 2.95% | 0.00% |
| July 21, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Performance Stock Units | 150000 | $0.00 | 900,000.0000 | 352,470,796 | 20.00% | 0.04% |
| June 13, 2025 | Bonnefoy Luc | President, Surgical | F | Common Shares, No Par Value | 968 | $12.33 | 73,383.0000 | 352,470,796 | 1.30% | 0.00% |
| May 27, 2025 | Bernier Nathalie D. | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 69,663.0000 | 352,470,796 | 41.23% | 0.01% |
| May 27, 2025 | VON ESCHENBACH ANDREW C. | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 62,086.0000 | 352,470,796 | 48.72% | 0.01% |
| May 27, 2025 | Ross Thomas W. Sr. | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 60,391.0000 | 352,470,796 | 50.78% | 0.01% |
| May 27, 2025 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 64,914.0000 | 352,470,796 | 45.63% | 0.01% |
| May 27, 2025 | Paulson John | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 69,965.0000 | 352,470,796 | 40.98% | 0.01% |
| May 27, 2025 | Ling Karen | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 37,676.0000 | 352,470,796 | 117.30% | 0.01% |
| May 27, 2025 | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 53,699.0000 | 352,470,796 | 60.96% | 0.01% |
| May 27, 2025 | ICAHN BRETT | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 61,147.0000 | 352,470,796 | 49.84% | 0.01% |
| May 27, 2025 | Hu Gaoxiang | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 61,147.0000 | 352,470,796 | 49.84% | 0.01% |
| May 22, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | P | Common Shares, No Par Value | 22000 | $11.28 | 719,156.0000 | 352,470,796 | 3.16% | 0.01% |
| May 22, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 22000 | $0.00 | 741,156.0000 | 352,470,796 | 3.06% | 0.01% |
| May 2, 2025 | VON ESCHENBACH ANDREW C. | Director | P | Common Shares, No Par Value | 1695 | $11.76 | 41,748.0000 | 352,470,796 | 4.23% | 0.00% |
| May 1, 2025 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 2210 | $11.59 | 44,576.0000 | 352,470,796 | 5.22% | 0.00% |
| May 1, 2025 | Paulson John | Director | A | Common Shares, No Par Value | 1887 | $11.59 | 49,627.0000 | 352,470,796 | 3.95% | 0.00% |
| April 24, 2025 | Stewart Andrew J. | See remarks | F | Common Shares, No Par Value | 3954 | $13.89 | 62,930.0000 | 352,470,796 | 5.91% | 0.00% |
| April 24, 2025 | Bailey A Robert D | EVP & Chief Legal Officer | F | Common Shares, No Par Value | 9781 | $13.89 | 170,576.0000 | 352,470,796 | 5.42% | 0.00% |
| Feb. 28, 2025 | Bonnefoy Luc | President,Surgical | F | Common Shares, No Par Value | 3029 | $16.00 | 74,351.0000 | 352,470,796 | 3.91% | 0.00% |
| Feb. 28, 2025 | Bonnefoy Luc | President,Surgical | F | Common Shares, No Par Value | 1110 | $16.00 | 77,380.0000 | 352,470,796 | 1.41% | 0.00% |
| Feb. 26, 2025 | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 25225 | $0.00 | 119,580.0000 | 352,470,796 | 26.73% | 0.01% |
| Feb. 26, 2025 | Hashad Yehia | EVP of R&D and CMO | A | Non-Qualified Stock Options (right to purchase) | 60085 | $0.00 | 60,085.0000 | 352,470,796 | 9999.99% | 0.02% |
| Feb. 26, 2025 | Bailey A Robert D | EVP & Chief Legal Officer | A | Common Shares, No Par Value | 40540 | $0.00 | 180,357.0000 | 352,470,796 | 29.00% | 0.01% |
| Feb. 26, 2025 | Bailey A Robert D | EVP & Chief Legal Officer | A | Non-Qualified Stock Options (right to purchase) | 96566 | $15.86 | 96,566.0000 | 352,470,796 | 9999.99% | 0.03% |
| Feb. 26, 2025 | Eldessouky Sam | EVP and CFO | A | Common Shares, No Par Value | 59459 | $0.00 | 282,295.0000 | 352,470,796 | 26.68% | 0.02% |
| Feb. 26, 2025 | Munsch Frederick | SVP, Controller and CAO | A | Common Shares, No Par Value | 18581 | $0.00 | 71,294.0000 | 352,470,796 | 35.25% | 0.01% |
| Feb. 26, 2025 | Bonnefoy Luc | President,Surgical | A | Common Shares, No Par Value | 23423 | $0.00 | 78,490.0000 | 352,470,796 | 42.54% | 0.01% |
| Feb. 26, 2025 | Bonnefoy Luc | President,Surgical | A | Non-Qualified Stock Options (right to purchase) | 55793 | $0.00 | 55,793.0000 | 352,470,796 | 9999.99% | 0.02% |
| Feb. 26, 2025 | Stewart Andrew J. | See remarks | A | Common Shares, No Par Value | 23423 | $0.00 | 66,884.0000 | 352,470,796 | 53.89% | 0.01% |
| Feb. 26, 2025 | Stewart Andrew J. | See remarks | A | Non-Qualified Stock Options (right to purchase) | 55793 | $0.00 | 55,793.0000 | 352,470,796 | 9999.99% | 0.02% |
| Feb. 26, 2025 | Eldessouky Sam | EVP and CFO | A | Non-Qualified Stock Options (right to purchase) | 141630 | $0.00 | 141,630.0000 | 352,470,796 | 9999.99% | 0.04% |
| Feb. 26, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 168168 | $0.00 | 697,156.0000 | 352,470,796 | 31.79% | 0.05% |
| Feb. 26, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Non-Qualified Stock Options (right to purchase) | 600858 | $0.00 | 600,858.0000 | 352,470,796 | 9999.99% | 0.17% |
| Dec. 23, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | F | Common Shares, No Par Value | 4402 | $17.83 | 139,817.0000 | 353,900,000 | 3.05% | 0.00% |
| Dec. 23, 2024 | Stewart Andrew J. | See remarks | F | Common Shares, No Par Value | 2524 | $17.83 | 43,461.0000 | 353,900,000 | 5.49% | 0.00% |
| Dec. 23, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 73782 | $17.83 | 553,637.0000 | 353,900,000 | 11.76% | 0.02% |
| Dec. 23, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 24649 | $17.83 | 528,988.0000 | 353,900,000 | 4.45% | 0.01% |
| Dec. 23, 2024 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 908 | $17.83 | 54,905.0000 | 353,900,000 | 1.63% | 0.00% |
| Dec. 23, 2024 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 2192 | $17.83 | 52,713.0000 | 353,900,000 | 3.99% | 0.00% |
| Dec. 23, 2024 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2324 | $17.83 | 97,106.0000 | 353,900,000 | 2.34% | 0.00% |
| Dec. 23, 2024 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2751 | $17.83 | 94,355.0000 | 353,900,000 | 2.83% | 0.00% |
| Dec. 23, 2024 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 7249 | $17.83 | 231,418.0000 | 353,900,000 | 3.04% | 0.00% |
| Dec. 23, 2024 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 8582 | $17.83 | 222,836.0000 | 353,900,000 | 3.71% | 0.00% |
| Sept. 30, 2024 | Paulson John | Director | A | Common Shares, No Par Value | 1134 | $19.29 | 48,874.0000 | 350,500,000 | 2.38% | 0.00% |
| Sept. 30, 2024 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 1328 | $19.29 | 43,694.0000 | 350,500,000 | 3.13% | 0.00% |
| Aug. 5, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | P | Common Shares, No Par Value | 32250 | $15.66 | 595,169.0000 | 350,500,000 | 5.73% | 0.01% |
| Aug. 5, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 32250 | $0.00 | 627,419.0000 | 350,500,000 | 5.42% | 0.01% |
| Aug. 2, 2024 | Paulson John | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 47,740.0000 | 350,500,000 | 44.47% | 0.00% |
| Aug. 2, 2024 | Bernier Nathalie D. | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 49,325.0000 | 350,500,000 | 42.44% | 0.00% |
| Aug. 2, 2024 | Hu Gaoxiang | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 40,809.0000 | 350,500,000 | 56.28% | 0.00% |
| Aug. 2, 2024 | ICAHN BRETT | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 40,809.0000 | 350,500,000 | 56.28% | 0.00% |
| Aug. 2, 2024 | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 33,361.0000 | 350,500,000 | 78.74% | 0.00% |
| Aug. 2, 2024 | Ling Karen | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 17,338.0000 | 350,500,000 | 556.25% | 0.00% |
| Aug. 2, 2024 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 42,366.0000 | 350,500,000 | 53.11% | 0.00% |
| Aug. 2, 2024 | Ross Thomas W. Sr. | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 40,053.0000 | 350,500,000 | 57.96% | 0.00% |
| Aug. 2, 2024 | VON ESCHENBACH ANDREW C. | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 40,053.0000 | 350,500,000 | 57.96% | 0.00% |
| July 25, 2024 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 5113 | $15.53 | 238,667.0000 | 350,500,000 | 2.10% | 0.00% |
| July 25, 2024 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 1313 | $15.53 | 55,813.0000 | 350,500,000 | 2.30% | 0.00% |
| July 25, 2024 | Bonnefoy Luc | President,Surgical | F | Common Shares, No Par Value | 2144 | $15.53 | 55,067.0000 | 350,500,000 | 3.75% | 0.00% |
| July 25, 2024 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2841 | $15.53 | 99,430.0000 | 350,500,000 | 2.78% | 0.00% |
| June 28, 2024 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 1764 | $14.52 | 27,670.0000 | 350,500,000 | 6.81% | 0.00% |
| June 28, 2024 | Paulson John | Director | A | Common Shares, No Par Value | 1506 | $14.52 | 33,044.0000 | 350,500,000 | 4.78% | 0.00% |
| June 14, 2024 | Bonnefoy Luc | President,Surgical | F | Common Shares, No Par Value | 958 | $15.09 | 57,211.0000 | 350,500,000 | 1.65% | 0.00% |
| April 24, 2024 | Stewart Andrew J. | See remarks | F | Common Shares, No Par Value | 3943 | $14.90 | 45,985.0000 | 350,500,000 | 7.90% | 0.00% |
| April 24, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | F | Common Shares, No Par Value | 9838 | $14.90 | 144,219.0000 | 350,500,000 | 6.39% | 0.00% |
| March 29, 2024 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 1481 | $17.30 | 25,906.0000 | 350,500,000 | 6.06% | 0.00% |
| March 29, 2024 | DE SCHUTTER RICHARD U | Director | A | Common Shares, No Par Value | 1553 | $17.30 | 32,952.0000 | 350,500,000 | 4.95% | 0.00% |
| March 29, 2024 | Paulson John | Director | A | Common Shares, No Par Value | 1264 | $17.30 | 31,538.0000 | 350,500,000 | 4.18% | 0.00% |
| March 5, 2024 | Ling Karen | Director | A | Common Shares, No Par Value | 2642 | $0.00 | 2,642.0000 | 350,500,000 | 9999.99% | 0.00% |
| March 1, 2024 | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2143 | $16.47 | 102,271.0000 | 350,500,000 | 2.05% | 0.00% |
| March 1, 2024 | Eldessouky Sam | EVP and CFO | F | Common Shares, No Par Value | 4854 | $16.47 | 243,780.0000 | 350,500,000 | 1.95% | 0.00% |
| March 1, 2024 | Bonnefoy Luc | President,Surgical | F | Common Shares, No Par Value | 1098 | $16.47 | 58,169.0000 | 350,500,000 | 1.85% | 0.00% |
| March 1, 2024 | Munsch Frederick | SVP, Controller and CAO | F | Common Shares, No Par Value | 995 | $16.47 | 57,126.0000 | 350,500,000 | 1.71% | 0.00% |
| Feb. 28, 2024 | SAUNDERS BRENT L | CEO and Chair | A | Common Shares, No Par Value | 187919 | $0.00 | 562,919.0000 | 350,500,000 | 50.11% | 0.05% |
| Feb. 28, 2024 | Eldessouky Sam | EVP and CFO | A | Non-Qualified Stock Options (right to purchase) | 152439 | $0.00 | 152,439.0000 | 350,500,000 | 9999.99% | 0.04% |
| Feb. 28, 2024 | Eldessouky Sam | EVP and CFO | A | Common Shares, No Par Value | 50335 | $0.00 | 248,634.0000 | 350,500,000 | 25.38% | 0.01% |
| Feb. 28, 2024 | Stewart Andrew J. | See remarks | A | Non-Qualified Stock Options (right to purchase) | 50813 | $0.00 | 50,813.0000 | 350,500,000 | 9999.99% | 0.01% |
| Feb. 28, 2024 | Stewart Andrew J. | See remarks | A | Common Shares, No Par Value | 16778 | $0.00 | 49,928.0000 | 350,500,000 | 50.61% | 0.00% |
| Feb. 28, 2024 | Bonnefoy Luc | President,Surgical | A | Non-Qualified Stock Options (right to purchase) | 50813 | $0.00 | 50,813.0000 | 350,500,000 | 9999.99% | 0.01% |
| Feb. 28, 2024 | Bonnefoy Luc | President,Surgical | A | Common Shares, No Par Value | 16778 | $0.00 | 59,267.0000 | 350,500,000 | 39.49% | 0.00% |
| Feb. 28, 2024 | Hashad Yehia | EVP of R&D and CMO | A | Non-Qualified Stock Options (right to purchase) | 63516 | $0.00 | 63,516.0000 | 350,500,000 | 9999.99% | 0.02% |
| Feb. 28, 2024 | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 20973 | $0.00 | 104,414.0000 | 350,500,000 | 25.14% | 0.01% |
| Feb. 28, 2024 | Munsch Frederick | SVP, Controller and CAO | A | Common Shares, No Par Value | 18183 | $0.00 | 58,121.0000 | 350,500,000 | 45.53% | 0.01% |
| Feb. 28, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | A | Non-Qualified Stock Options (right to purchase) | 101626 | $0.00 | 101,626.0000 | 350,500,000 | 9999.99% | 0.03% |
| Feb. 28, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | A | Common Shares, No Par Value | 33557 | $0.00 | 154,057.0000 | 350,500,000 | 27.85% | 0.01% |
| Feb. 28, 2024 | SAUNDERS BRENT L | CEO and Chair | A | Non-Qualified Stock Options (right to purchase) | 569105 | $0.00 | 569,105.0000 | 350,500,000 | 9999.99% | 0.16% |
| Dec. 29, 2023 | DE SCHUTTER RICHARD U | Director | A | Common Shares, No Par Value | 1575 | $17.06 | 31,399.0000 | 350,200,000 | 5.28% | 0.00% |
| Dec. 29, 2023 | ROBERTSON RUSSEL C | Director | A | Common Shares, No Par Value | 1502 | $17.06 | 24,425.0000 | 350,200,000 | 6.55% | 0.00% |
| Dec. 29, 2023 | Bernier Nathalie D. | Director | A | Common Shares, No Par Value | 1465 | $17.06 | 34,629.0000 | 350,200,000 | 4.42% | 0.00% |
| Dec. 29, 2023 | Paulson John | Director | A | Common Shares, No Par Value | 1282 | $17.06 | 30,274.0000 | 350,200,000 | 4.42% | 0.00% |